Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Subscribe to see Cibus, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cibus, Inc. is an agricultural biotechnology company headquartered in San Diego, United States. It is publicly listed (CBUS) with a market capitalisation of $83.3M. Xcout tracks 25 named people at Cibus, Inc., including Craig Wichner (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
19 more named people on record for Cibus, Inc., with roles, board committees and tenure — see the full roster →
62 institutions reported a position for the quarter ending 30 June 2026.
The full list of 62 institutions, with share counts and what each bought or sold since the previous quarter.
Sign in to see it, or subscribe →
Source: SEC Form 13F filings, period ending 30 June 2026; shares outstanding from the company's 10-Q as of 28 April 2023. 13F covers the US-listed holdings of investment managers with more than $100 million under management and is filed up to 45 days after the quarter ends. A firm that files under several names (Vanguard files as two managers) is one row, with its filers listed under it. Insiders and retail holders are in “not held by 13F institutions”. The reported shares outstanding look inconsistent with the holdings, so no percentage is shown.
A few of Cibus, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cirsium Biosciences is a San Diego-based biotech company focused on democratizing gene therapy. The company is redefining AAV production through transformative viral vector production methods and systems.
Cytonus Therapeutics, Inc. is a San Diego-based biotherapeutic and biotechnology company headquartered in Carlsbad, California. The company develops transformative medicines utilizing a vast platform of proprietary targeted drug delivery systems based on next-generation artificial intelligence and life sciences research.
Base Therapeutics is a biotechnology company that develops next-generation gene editing technologies, including its proprietary AccuBase base editing system and enhanced prime editing technology. The company focuses on creating therapeutic solutions for cancer and genetic diseases, alongside engineered immune cell therapies such as BASE-NK and CAR-T products. It serves patients and partners with pharmaceutical and agricultural enterprises by licensing its precision gene editing tools.
CropBiome is a biotechnology research company headquartered in Dublin, Ireland. Founded in 2018, the firm develops natural microbiome-based seed treatments and crop enhancement solutions to improve agricultural yields sustainably.
Founded in 2020 and headquartered in Cambridge, Massachusetts, Robigo is a biotechnology company that engineers biological solutions designed to outperform synthetic chemistries while protecting biodiversity and human health. The firm focuses on agricultural applications, drawing its name from a female Roman deity who protected grain fields from disease.
Inari Agriculture, Inc. is an agricultural biotechnology company headquartered in Cambridge, Massachusetts. The company leverages an advanced AI-enabled SEEDesign platform to transform seed technology and crop performance.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Cibus, Inc.? Suggest a correction · Work at Cibus, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.